These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8691581)

  • 1. [Mechanism of action of antileukemic agents in leukemia chemotherapy].
    Nakamura T
    Rinsho Ketsueki; 1996 May; 37(5):380-91. PubMed ID: 8691581
    [No Abstract]   [Full Text] [Related]  

  • 2. Topoisomerase II and the response to antileukemic therapy.
    Kaufmann SH; Gore SD; Miller CB; Jones RJ; Zwelling LA; Schneider E; Burke PJ; Karp JE
    Leuk Lymphoma; 1998 Apr; 29(3-4):217-37. PubMed ID: 9684921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Action mechanism of antileukemic agents with special reference to nucleic acid metabolism of leukemic cells.
    Nakamura T
    Nihon Ketsueki Gakkai Zasshi; 1982 Dec; 45(7):1203-18. PubMed ID: 6762793
    [No Abstract]   [Full Text] [Related]  

  • 4. [Antimetabolites in the therapy of human acute leukemia. Mechanism of action and factors conditioning the cellular response to the drugs. 3. Cellular kinetics and chemotherapy].
    Grignani F; Martelli M; Tonato M
    Clin Ter; 1974 Mar; 69(3):263-79. PubMed ID: 4846658
    [No Abstract]   [Full Text] [Related]  

  • 5. Chemotherapy of acute leukemia from the viewpoint of the action mechanism of antitumor agents.
    Nakamura T
    Nihon Ketsueki Gakkai Zasshi; 1980 Dec; 43(6):1022-33. PubMed ID: 7331684
    [No Abstract]   [Full Text] [Related]  

  • 6. Mechanism of action of antileukemic agents and their clinical effects.
    Nakamura T; Tatsumi K; Higuchi T; Shirakawa S; Wakisaka G
    Nihon Ketsueki Gakkai Zasshi; 1974 Jun; 37(3):302-15. PubMed ID: 4479921
    [No Abstract]   [Full Text] [Related]  

  • 7. [Recent progress in the treatment of hematological malignancies. I. Anticancer agents].
    Wakisaka G; Nakamura T
    Nihon Naika Gakkai Zasshi; 1989 Jun; 78(6):753-8. PubMed ID: 2794656
    [No Abstract]   [Full Text] [Related]  

  • 8. Superior cytotoxic potency of mitoxantrone in interaction with DNA: comparison with that of daunorubicin.
    Fukushima T; Kawai Y; Nakayama T; Yamauchi T; Yoshida A; Urasaki Y; Imamura S; Kamiya K; Tsutani H; Ueda T; Nakamura T
    Oncol Res; 1996; 8(2):95-100. PubMed ID: 8859780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surveillance of the serum Candida antigen titer for initiation of antifungal therapy after post-remission chemotherapy in patients with acute leukemia.
    Iwasaki H; Misaki H; Nakamura T; Ueda T
    Int J Hematol; 2000 Apr; 71(3):266-72. PubMed ID: 10846834
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokinetics and chemotherapy of human acute leukemia.
    Ernst P
    Dan Med Bull; 1976 Dec; 23(6):257-66. PubMed ID: 1009794
    [No Abstract]   [Full Text] [Related]  

  • 11. [The prognostic role of determining spontaneous leukocyte DNA damage and that occurring during chemotherapy in leukemia patients].
    Morozova EO; Sidorova ZhIu; Blinov MN; Moiseev SI; Samuskevich IG; Shcherbakova EG; Abdulkadyrov KM
    Vestn Ross Akad Med Nauk; 1993; (4):20-5. PubMed ID: 7687479
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The discovery and development of new antileukemic drugs.
    Grever M; Malspeis L
    Hematol Oncol Clin North Am; 1993 Feb; 7(1):233-54. PubMed ID: 8449860
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Principles of chemotherapy of acute leukaemia.
    Holland JF
    Triangle; 1967; 8(2):53-64. PubMed ID: 5602880
    [No Abstract]   [Full Text] [Related]  

  • 14. New antileukemic agents.
    Mantadakis E; Kalmanti M
    Pediatr Hematol Oncol; 2003; 20(3):173-85. PubMed ID: 12637214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of antileukemic treatment according to the parameters of the activity of lactate dehydrogenase of the blast cells].
    Vialushkina MD; Kurmashov VI; Nartsissov RP
    Probl Gematol Pereliv Krovi; 1977 Sep; 22(9):50-1. PubMed ID: 928351
    [No Abstract]   [Full Text] [Related]  

  • 16. Nelarabine activity in acute biphenotypic leukemia.
    Alvarado Y; Welch MA; Swords R; Bruzzi J; Schlette E; Giles FJ
    Leuk Res; 2007 Nov; 31(11):1600-3. PubMed ID: 17512588
    [No Abstract]   [Full Text] [Related]  

  • 17. Metallothionein expression prevents apoptosis. II: Evaluation of the role of metallothionein expression on the chemotherapy-induced apoptosis during the treatment of acute leukemia.
    Tsangaris GT; Vamvoukakis J; Politis I; Kattamis AC; Tzortzatou-Stathopoulou F
    Anticancer Res; 2000; 20(6B):4407-11. PubMed ID: 11205280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The chief trends in the search for antileukemic therapeutic agents].
    Chernov VA; Safonova TS
    Probl Gematol Pereliv Krovi; 1965 Dec; 10(12):3-13. PubMed ID: 5334870
    [No Abstract]   [Full Text] [Related]  

  • 19. Cloretazine for the treatment of acute myeloid leukemia.
    Vey N; Giles F
    Expert Rev Anticancer Ther; 2006 Mar; 6(3):321-8. PubMed ID: 16503849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Permanent lymphoblastic cell cultures as model for study of action mechanism of antileukemic substances].
    Wilms K; Wilmanns W
    Verh Dtsch Ges Inn Med; 1973; 79():1379-81. PubMed ID: 4790189
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.